These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 28143439

  • 101.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 102.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 103. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
    Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsagué X, Skinner SR, Apter D, Naud P, Salmerón J, Chow SN, Kitchener H, Teixeira JC, Hedrick J, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, De Carvalho NS, Germar MJ, Peters K, Mindel A, De Sutter P, Bosch FX, David MP, Descamps D, Struyf F, Dubin G, HPV PATRICIA Study Group.
    Lancet Oncol; 2012 Jan; 13(1):89-99. PubMed ID: 22075171
    [Abstract] [Full Text] [Related]

  • 104.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 105. Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance.
    Brotherton JM, Tabrizi SN, Garland SM.
    Future Microbiol; 2012 Feb; 7(2):193-9. PubMed ID: 22324989
    [Abstract] [Full Text] [Related]

  • 106. HPV genotype distribution according to severity of cervical neoplasia.
    Sjoeborg KD, Tropé A, Lie AK, Jonassen CM, Steinbakk M, Hansen M, Jacobsen MB, Cuschieri K, Eskild A.
    Gynecol Oncol; 2010 Jul; 118(1):29-34. PubMed ID: 20406711
    [Abstract] [Full Text] [Related]

  • 107. Urine human papillomavirus prevalence in women with high-grade cervical lesions.
    Nicolau P, Mancebo G, Agramunt S, Solé-Sedeño JM, Bellosillo B, Muset MM, Lloveras B, Alameda F, Carreras R.
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():12-5. PubMed ID: 25461344
    [Abstract] [Full Text] [Related]

  • 108. Prevalence and type distribution of human papillomavirus in women with cervical lesions in Liaoning Province, China.
    Liu X, Zhang S, Ruan Q, Ji Y, Ma L, Zhang Y.
    Int J Gynecol Cancer; 2010 Jan; 20(1):147-53. PubMed ID: 20130516
    [Abstract] [Full Text] [Related]

  • 109.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 110.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 111.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 112.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 113.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 114.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 115. Prevalence, risk factors and genotype distribution of human papillomavirus infection among women with and without invasive cervical cancer: Findings from a hospital-based study in Bihar, India.
    Pankaj S, Rani J, Kumari P, Abhilashi K, Choudhary V, Kumari S, Shahi SK, Jee B.
    Natl Med J India; 2024 Jan; 37(1):13-17. PubMed ID: 39096228
    [Abstract] [Full Text] [Related]

  • 116.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 117. Impact of human papillomavirus types on uterine cervical neoplasia.
    Taguchi A, Yoshimoto D, Kusakabe M, Baba S, Kawata A, Miyamoto Y, Mori M, Sone K, Hirota Y, Osuga Y.
    J Obstet Gynaecol Res; 2024 Aug; 50(8):1283-1288. PubMed ID: 38852606
    [Abstract] [Full Text] [Related]

  • 118.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 119.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 120. The distribution and prevalence of human papillomavirus in women in mainland China.
    Li K, Li Q, Song L, Wang D, Yin R.
    Cancer; 2019 Apr 01; 125(7):1030-1037. PubMed ID: 30748006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.